Correlates of Perceived Discrimination Related to Substance Use Disorders Among Patients in Methadone Maintenance Treatment

Overview

Journal J Psychoactive Drugs

Specialties Pharmacology
Psychiatry

Date 2023 Jul 3

PMID 37399330

Authors

Uzoji Nwanaji-Enwerem

Mark Beitel

David E Oberleitner

Marina Gaeta Gazzola

Kathryn F Eggert

Lindsay M S Oberleitner

Oluwole Jegede

Xiaoying Zheng

Nancy S Redeker

Lynn M Madden

Declan T Barry

Affiliations

Soon will be listed here.

Abstract

This study sought to examine demographic, treatment-related, and diagnosis-related correlates of substance use disorder (SUD)-related perceived discrimination among patients receiving methadone maintenance treatment (MMT). Participants were 164 patients at nonprofit, low-barrier-to-treatment-access MMT programs. Participants completed measures of demographics, diagnosis-related characteristics (Brief Symptom Inventory (BSI-18) and Depressive Experiences Questionnaire (DEQ)), and treatment-related characteristics. Perceived discrimination was measured on a seven-point Likert-type scale ranging from 1 ("Not at all") to 7 ("Extremely") in response to the item: "I often feel discriminated against because of my substance abuse." Given the variable's distribution, a median split was used to categorize participants into "high" and "low" discrimination groups. Correlates of high and low discrimination were analyzed with bivariate and logistic regression models. Ninety-four participants (57%) reported high SUD-related perceived discrimination. Bivariate analyses identified six statistically significant correlates of SUD-related perceived discrimination ( < .05): age, race, age of onset of opioid use disorder, BSI-18 Depression, DEQ Dependency, and DEQ Self-Criticism. In the final logistic regression model, those with high (versus low) SUD-related perceived discrimination were more likely to report depressive symptoms and be self-critical. Patients in MMT with high compared to low SUD-related perceived discrimination may be more likely to report being depressed and self-critical.

References

Vu M, Li J, Haardorfer R, Windle M, Berg C . Mental health and substance use among women and men at the intersections of identities and experiences of discrimination: insights from the intersectionality framework. BMC Public Health. 2019; 19(1):108. PMC: 6345035. DOI: 10.1186/s12889-019-6430-0. View

Simon C, Vincent L, Coulter A, Salazar Z, Voyles N, Roberts L . The Methadone Manifesto: Treatment Experiences and Policy Recommendations From Methadone Patient Activists. Am J Public Health. 2022; 112(S2):S117-S122. PMC: 8965191. DOI: 10.2105/AJPH.2021.306665. View

Pascoe E, Richman L . Perceived discrimination and health: a meta-analytic review. Psychol Bull. 2009; 135(4):531-54. PMC: 2747726. DOI: 10.1037/a0016059. View

Esses V . Prejudice and Discrimination Toward Immigrants. Annu Rev Psychol. 2020; 72:503-531. DOI: 10.1146/annurev-psych-080520-102803. View

McKnight C, Shumway M, Masson C, Pouget E, Jordan A, Des Jarlais D . Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization. J Ethn Subst Abuse. 2017; 16(4):404-419. PMC: 6155481. DOI: 10.1080/15332640.2017.1292418. View

Jegede O, Muvvala S, Katehis E, Paul S, Soipe A, Jolayemi A . Perceived barriers to access care, anticipated discrimination and structural vulnerability among African Americans with substance use disorders. Int J Soc Psychiatry. 2020; 67(2):136-143. DOI: 10.1177/0020764020934512. View

Barry D, Fulgieri M, Lavery M, Chawarski M, Najavits L, Schottenfeld R . Research- and community-based clinicians' attitudes on treatment manuals. Am J Addict. 2008; 17(2):145-8. DOI: 10.1080/10550490701860880. View

Roy P, Choi S, Bernstein E, Walley A . Appointment wait-times and arrival for patients at a low-barrier access addiction clinic. J Subst Abuse Treat. 2020; 114:108011. DOI: 10.1016/j.jsat.2020.108011. View

Woo J, Bhalerao A, Bawor M, Bhatt M, Dennis B, Mouravska N . "Don't Judge a Book Its Cover": A Qualitative Study of Methadone Patients' Experiences of Stigma. Subst Abuse. 2017; 11:1178221816685087. PMC: 5398333. DOI: 10.1177/1178221816685087. View

10.

Volkow N, Gordon J, Koob G . Choosing appropriate language to reduce the stigma around mental illness and substance use disorders. Neuropsychopharmacology. 2021; 46(13):2230-2232. PMC: 8580983. DOI: 10.1038/s41386-021-01069-4. View

11.

Palis H, Marchand K, Peng D, Fikowski J, Harrison S, Spittal P . Factors Associated with Perceived Abuse in the Health Care System Among Long-Term Opioid Users: A Cross-Sectional Study. Subst Use Misuse. 2016; 51(6):763-76. DOI: 10.3109/10826084.2016.1155605. View

12.

Lin C, Wu Z, Detels R . Opiate users' perceived barriers against attending methadone maintenance therapy: a qualitative study in China. Subst Use Misuse. 2011; 46(9):1190-8. PMC: 3392119. DOI: 10.3109/10826084.2011.561905. View

13.

Tsai A, Kiang M, Barnett M, Beletsky L, Keyes K, McGinty E . Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med. 2019; 16(11):e1002969. PMC: 6957118. DOI: 10.1371/journal.pmed.1002969. View

14.

Luoma J, Twohig M, Waltz T, Hayes S, Roget N, Padilla M . An investigation of stigma in individuals receiving treatment for substance abuse. Addict Behav. 2006; 32(7):1331-46. DOI: 10.1016/j.addbeh.2006.09.008. View

15.

Rog D, Marshall T, Dougherty R, George P, Daniels A, Ghose S . Permanent supportive housing: assessing the evidence. Psychiatr Serv. 2013; 65(3):287-94. DOI: 10.1176/appi.ps.201300261. View

16.

Etesam F, Assarian F, Hosseini H, Ghoreishi F . Stigma and its determinants among male drug dependents receiving methadone maintenance treatment. Arch Iran Med. 2014; 17(2):108-14. DOI: 014172/AIM.005. View

17.

Otiniano Verissimo A, Gee G, Ford C, Iguchi M . Racial discrimination, gender discrimination, and substance abuse among Latina/os nationwide. Cultur Divers Ethnic Minor Psychol. 2014; 20(1):43-51. PMC: 4060885. DOI: 10.1037/a0034674. View

18.

Lin L, Bohnert A, Blow F, Gordon A, Ignacio R, Kim H . Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction. 2020; 116(1):96-104. DOI: 10.1111/add.15116. View

19.

Marchand K, Palis H, Oviedo-Joekes E . Patient Perceptions of Prejudice and Discrimination by Health Care Providers and its Relationship with Mental Disorders: Results from the 2012 Canadian Community Health-Mental Health Survey Data. Community Ment Health J. 2015; 52(3):294-301. DOI: 10.1007/s10597-015-9949-2. View

20.

Blanco C, Volkow N . Management of opioid use disorder in the USA: present status and future directions. Lancet. 2019; 393(10182):1760-1772. DOI: 10.1016/S0140-6736(18)33078-2. View